Literature DB >> 22140375

Severe Myoclonic Epilepsy in Infancy - Adult Phenotype with Bradykinesia, Hypomimia, and Perseverative Behavior: Report of Five Cases.

P Martin1, B Rautenstrauβ, A Abicht, J Fahrbach, S Koster.   

Abstract

Dravet syndrome or severe myoclonic epilepsy in infancy (SMEI) is an epileptic syndrome characterised by refractory epilepsy and intellectual disability, typically presenting with febrile and afebrile generalised and unilateral clonic/tonic-clonic seizures in the first year of life and other types of seizures appearing later in the course of the disease. Five adult patients with SMEI and SCN1A mutations are reported, in which motor and behavioural abnormalities were outstanding symptoms. Bradykinesia, responding with latency, slow speaking with a thin voice, midface hypomimia and perseveration were distinctive features in all cases. These symptoms may be fit to define the adult phenotype of SMEI beyond seizure/epilepsy criteria. The motor and behavioural symptoms are discussed in the context of a possibly underlying frontal lobe/mesofrontal and cerebellar dysfunction.

Entities:  

Year:  2011        PMID: 22140375      PMCID: PMC3214946          DOI: 10.1159/000326746

Source DB:  PubMed          Journal:  Mol Syndromol        ISSN: 1661-8769


  31 in total

1.  Is evaluation of humorous stimuli associated with frontal cortex morphology? A pilot study using facial micro-movement analysis and MRI.

Authors:  Georg Juckel; Roland Mergl; Martin Brüne; Isabelle Villeneuve; Thomas Frodl; Gisela Schmitt; Thomas Zetzsche; Christine Born; Klaus Hahn; Maximilian Reiser; Hans-Jürgen Möller; Karl-Jürgen Bär; Ulrich Hegerl; Eva Maria Meisenzahl
Journal:  Cortex       Date:  2010-04-21       Impact factor: 4.027

2.  Nav1.1 is predominantly expressed in nodes of Ranvier and axon initial segments.

Authors:  Amandine Duflocq; Barbara Le Bras; Erika Bullier; François Couraud; Marc Davenne
Journal:  Mol Cell Neurosci       Date:  2008-06-24       Impact factor: 4.314

Review 3.  A catalog of SCN1A variants.

Authors:  Christoph Lossin
Journal:  Brain Dev       Date:  2008-09-19       Impact factor: 1.961

4.  Epidemiology of severe myoclonic epilepsy of infancy.

Authors:  D L Hurst
Journal:  Epilepsia       Date:  1990 Jul-Aug       Impact factor: 5.864

5.  Reduced sodium current in GABAergic interneurons in a mouse model of severe myoclonic epilepsy in infancy.

Authors:  Frank H Yu; Massimo Mantegazza; Ruth E Westenbroek; Carol A Robbins; Franck Kalume; Kimberly A Burton; William J Spain; G Stanley McKnight; Todd Scheuer; William A Catterall
Journal:  Nat Neurosci       Date:  2006-08-20       Impact factor: 24.884

6.  Honored guest presentation: abulia minor vs. agitated behavior.

Authors:  C M Fisher
Journal:  Clin Neurosurg       Date:  1983

Review 7.  The dual-state theory of prefrontal cortex dopamine function with relevance to catechol-o-methyltransferase genotypes and schizophrenia.

Authors:  Daniel Durstewitz; Jeremy K Seamans
Journal:  Biol Psychiatry       Date:  2008-07-11       Impact factor: 13.382

8.  Spectrum of SCN1A gene mutations associated with Dravet syndrome: analysis of 333 patients.

Authors:  C Depienne; O Trouillard; C Saint-Martin; I Gourfinkel-An; D Bouteiller; W Carpentier; B Keren; B Abert; A Gautier; S Baulac; A Arzimanoglou; C Cazeneuve; R Nabbout; E LeGuern
Journal:  J Med Genet       Date:  2008-10-17       Impact factor: 6.318

9.  Reversible parkinsonism and cognitive impairment with chronic valproate use.

Authors:  C Armon; C Shin; P Miller; S Carwile; E Brown; J D Edinger; R G Paul
Journal:  Neurology       Date:  1996-09       Impact factor: 9.910

10.  Topography and collateralization of the dopaminergic projections to motor and lateral prefrontal cortex in owl monkeys.

Authors:  P Gaspar; I Stepniewska; J H Kaas
Journal:  J Comp Neurol       Date:  1992-11-01       Impact factor: 3.215

View more
  6 in total

1.  Audit of use of stiripentol in adults with Dravet syndrome.

Authors:  S Balestrini; S M Sisodiya
Journal:  Acta Neurol Scand       Date:  2016-05-27       Impact factor: 3.209

2.  Behavioral Comorbidities and Drug Treatments in a Zebrafish scn1lab Model of Dravet Syndrome.

Authors:  Brian P Grone; Tiange Qu; Scott C Baraban
Journal:  eNeuro       Date:  2017-08-14

Review 3.  Preclinical Animal Models for Dravet Syndrome: Seizure Phenotypes, Comorbidities and Drug Screening.

Authors:  Aliesha Griffin; Kyla R Hamling; SoonGweon Hong; Mana Anvar; Luke P Lee; Scott C Baraban
Journal:  Front Pharmacol       Date:  2018-06-04       Impact factor: 5.810

4.  Development of an antiseizure drug screening platform for Dravet syndrome at the NINDS contract site for the Epilepsy Therapy Screening Program.

Authors:  Chelsea D Pernici; Jeffrey A Mensah; E Jill Dahle; Kristina J Johnson; Laura Handy; Lauren Buxton; Misty D Smith; Peter J West; Cameron S Metcalf; Karen S Wilcox
Journal:  Epilepsia       Date:  2021-05-17       Impact factor: 6.740

5.  The Charlotte Project: Recommendations for patient-reported outcomes and clinical parameters in Dravet syndrome through a qualitative and Delphi consensus study.

Authors:  Ángel Aledo-Serrano; Ana Mingorance; Vicente Villanueva; Juan José García-Peñas; Antonio Gil-Nagel; Susana Boronat; JoséÁngel Aibar; Silvia Cámara; María José Yániz; Luis Miguel Aras; Bárbara Blanco; Rocío Sánchez-Carpintero
Journal:  Front Neurol       Date:  2022-09-01       Impact factor: 4.086

Review 6.  Dravet Syndrome: An Overview.

Authors:  Arsalan Anwar; Sidra Saleem; Urvish K Patel; Kogulavadanan Arumaithurai; Preeti Malik
Journal:  Cureus       Date:  2019-06-26
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.